SPA
Sherbrooke Park Advisers’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $94.8K | Sell |
12,538
-8,437
| -40% | -$63.8K | 0.04% | 466 |
|
|
2025
Q1 | $116K | Sell |
20,975
-12,476
| -37% | -$68.9K | 0.05% | 496 |
|
|
2024
Q4 | $192K | Buy |
+33,451
| New | +$192K | 0.06% | 598 |
|
|
2023
Q4 | – | Sell |
-10,100
| Closed | -$113K | – | 536 |
|
|
2023
Q3 | $113K | Buy |
+10,100
| New | +$113K | 0.04% | 445 |
|